September 20, 2017 4:38 AM ET

Pharmaceuticals

Company Overview of Helocyte Inc.

Company Overview

Helocyte Inc. engages in the development and commercialization of immunotherapies for the prevention and treatment of cytomegalovirus or CMV (cancer and infectious disease). It focuses on developing PepVax, a HLA-restricted single antigen peptide vaccine for controlling CMV in allogeneic hematopoietic stem cell transplant recipients; and Triplex, a universal recombinant viral vector vaccine expressing three immuno-dominant proteins, such as UL83 (pp65), UL123 (IE1), and UL122 (IE2) linked to CMV in the post-transplant setting; and Pentamer, a universal recombinant viral vector vaccine designed to induce a neutralizing antibody response to prevent the transmission of CMV from mother to fetus....

2 Gansevoort Street

9th Floor

New York, NY 10014

United States

Founded in 2015

Phone:

212-554-4520

Key Executives for Helocyte Inc.

Co-Founder, Chief Executive Officer, President and Director
Executive Chairman of The Board of Directors
Age: 62
Co-Founder and Chairman of Scientific Advisory Board
Interim Chief Financial Officer
Age: 49
Executive Vice President of Regulatory Affairs
Age: 67
Compensation as of Fiscal Year 2017.

Helocyte Inc. Key Developments

Helocyte Inc. Presents at Aegis Capital Corp. 2016 Growth Conference, Sep-21-2016 01:30 PM

Helocyte Inc. Presents at Aegis Capital Corp. 2016 Growth Conference, Sep-21-2016 01:30 PM. Venue: The Encore at Wynn Las Vegas, 3131 Las Vegas Blvd, Las Vegas, NV 89109, United States.

Helocyte Presents at 28th Annual ROTH Conference, Mar-15-2016 12:00 PM

Helocyte Presents at 28th Annual ROTH Conference, Mar-15-2016 12:00 PM. Venue: The Ritz Carlton, 1 Ritz Carlton Drive, Laguna Niguel, Dana Point, California, United States.

Similar Private Companies By Industry

Company Name Region
1st Order Pharmaceuticals, Inc. United States
21st Century Animal Health United States
3 Buds' Organics LLC United States
4P Therapeutics LLC United States
60° Pharmaceuticals, LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Tax Management Inc United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Helocyte Inc., please visit www.helocyte.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.